Drugs / aniracetam
aniracetam
also known as
1-p-anisoyl-2-pyrrolidinone · Ampamet · Draganon · Memodrin · NSC-758223 · RO 13-5057 · Sarpul
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07852130 | Mar → Sep 2026 | — | Abdulraheem Mohamed Gouda | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aniracetam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07852130 ↗ |
| Known as | 1-p-anisoyl-2-pyrrolidinone | ChEMBL registry synonym — accepted as the source's own label CHEMBL36994 ↗ |
| Known as | Ampamet | ChEMBL registry synonym — accepted as the source's own label CHEMBL36994 ↗ |
| Known as | Draganon | ChEMBL registry synonym — accepted as the source's own label CHEMBL36994 ↗ |
| Known as | Memodrin | ChEMBL registry synonym — accepted as the source's own label CHEMBL36994 ↗ |
| Known as | NSC-758223 | ChEMBL registry synonym — accepted as the source's own label CHEMBL36994 ↗ |
| Known as | RO 13-5057 | ChEMBL registry synonym — accepted as the source's own label CHEMBL36994 ↗ |
| Known as | Sarpul | ChEMBL registry synonym — accepted as the source's own label CHEMBL36994 ↗ |
| Modality | Small molecule | — CHEMBL36994 ↗ |